Understanding how the RUNX1 gene controls blood cell development
Mechanisms of RUNX1 transcriptional control in hematopoiesis
This project looks at how a gene called RUNX1 works to control the making of blood cells, which can help us understand conditions like familial platelet disorder and myeloid malignancy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project ID | NIH-11124105 on NIH RePORTER |
What this research studies
The RUNX1 gene is important for making healthy blood cells, and problems with this gene can lead to a condition called familial platelet disorder with a higher chance of developing blood cancers. Researchers are using a new technique to quickly turn off the RUNX1 protein in cells to see exactly how it affects gene activity. This rapid approach helps them pinpoint the direct changes caused by RUNX1, rather than indirect effects that build up over time. By understanding these precise mechanisms, we hope to learn more about how blood disorders develop. This knowledge could eventually lead to new ways to help patients with these conditions.
Who could benefit from this research
Good fit: Patients with familial platelet disorder, myeloid malignancy, or other blood conditions related to RUNX1 gene mutations may find this research relevant to their condition.
Not a fit: Patients whose conditions are not related to RUNX1 gene function or blood cell development would likely not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to a better understanding of blood disorders and blood cancers linked to the RUNX1 gene, potentially guiding the development of new treatments.
How similar studies have performed: While mouse models have shown the importance of RUNX1, this project uses a novel rapid protein removal technology to define its direct gene targets, which is a new approach for this specific question.
Where this research is happening
Bronx, United States
- Albert Einstein College of Medicine — Bronx, United States (Active)
Researchers
- Principal investigator: Stengel, Kristy — Albert Einstein College of Medicine
- Study coordinator: Stengel, Kristy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.